TCDA News and Press, Tricida Inc. From 11/07/22

3 Tips to Use for Buying Penny Stocks in November 2022 When it comes to penny stocks, there is a lot of debate as to whether or not they are worth investing in. Some people believe that penny stocks are a great way to make money, while others think that they are nothing more than a gamb...

3 Reasons You’re Not Profiting With Small Caps Penny stocks can be an incredibly lucrative investment opportunity, offering the potential for huge returns on a relatively small initial investment. However, many people are hesitant to try their hand at investing in penny stocks ...

Tricida ( NASDAQ: TCDA ) stock rose 3.2% postmarket on Wednesday after the drugmaker said it will initiate a review of strategic alternatives to maximize shareholder value. The strategic review may include a sale of the company and/or its assets. Tricida ( TCDA ...

Tricida, Inc. (NASDAQ: TCDA), announced today that the Board of Directors has authorized Tricida to initiate a review of strategic alternatives to maximize stakeholder value. To facilitate this review, Tricida has engaged Stifel and its wholly owned affiliate, Miller Buckfire, to serve ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Bukhta Yurii / Shutterstock.com Tricida (NASDAQ: TCDA ) stock is falling on Monday following the release of poor results from a Phase 3 clinical trial . That trial covers the use of veverimer to treat...

Tricida, Inc. ( NASDAQ: TCDA ) lost ~94% pre-market Monday after the South San Francisco, California-based pharma company said that its Phase 3 trial for kidney disease candidate veverimer did not meet the main goal. The VALOR-CKD trial evaluated oral therapy in patien...

Webcast today at 8:00 am Eastern Time Tricida, Inc. (NASDAQ: TCDA) announced today the top-line results from its VALOR-CKD renal outcomes clinical trial, designed to evaluate veverimer’s ability to slow CKD progression in patients with metabolic acidosis and chron...

Tricida ( NASDAQ: TCDA ) on Wednesday announced a $125M debt facility with Hercules Capital ( HTGC ). Of the total amount, $100M will be available for drawdown at Tricida's ( TCDA ) option subject to meeting certain targets. $25M will be available for drawdown ...

Tricida ( NASDAQ: TCDA ) gets into a debt facility of $125M with Hercules Capital, provider of customized debt financing for companies in the life sciences and technology-related markets. Of the $125M, $100M will be available for drawdown at Tricida’s optio...

Tricida, Inc. (Nasdaq: TCDA) announced today that it has entered into a debt facility with Hercules Capital, Inc. (NYSE: HTGC), a leader in customizing debt financing for companies in the life sciences and technology-related markets. The total amount of the debt facility is $125 million...